Guillain-Barré syndrome associated with Epstein-Barr virus and cytomegalovirus reactivation during treatment for chronic graft-versus-host disease after allogeneic bone marrow transplantation
Guillain-Barré syndrome (GBS) is a rare neurological complication of allogeneic hematopoietic stem cell transplantation (HSCT). The pathogenesis of post-HSCT GBS is unclear. Here, we report a case of GBS coincident with Epstein-Barr virus (EBV) and cytomegalovirus (CMV) reactivation that occurred after HSCT in a patient with myelodysplastic syndrome. A 61-year-old man was admitted to our hospital because of gait disturbance due to lower limb muscle weakness, which arose during treatment for chronic graft-versus-host disease (GVHD) five months after allogeneic HSCT. He was diagnosed with GBS based on his clinical course, cerebrospinal fluid analysis, and a nerve conduction study. At that time, he exhibited EBV and CMV reactivation. GBS improved after intravenous injection of immunoglobulins. Our case suggests that reactivation of EBV and CMV during treatment for chronic GVHD may induce GBS, and that rapidly progressive muscular weakness coincident with EBV or CMV reactivation can be a diagnostic sign of GBS after allogeneic HSCT.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
---|---|
Enthalten in: |
Rinsho ketsueki] The Japanese journal of clinical hematology - 64(2023), 10 vom: 29., Seite 1280-1285 |
Sprache: |
Japanisch |
---|
Beteiligte Personen: |
Hosoi, Hiroki [VerfasserIn] |
---|
Links: |
---|
Themen: |
Case Reports |
---|
Anmerkungen: |
Date Completed 03.11.2023 Date Revised 03.11.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.11406/rinketsu.64.1280 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM364061359 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM364061359 | ||
003 | DE-627 | ||
005 | 20231226094644.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||jpn c | ||
024 | 7 | |a 10.11406/rinketsu.64.1280 |2 doi | |
028 | 5 | 2 | |a pubmed24n1213.xml |
035 | |a (DE-627)NLM364061359 | ||
035 | |a (NLM)37914241 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a jpn | ||
100 | 1 | |a Hosoi, Hiroki |e verfasserin |4 aut | |
245 | 1 | 0 | |a Guillain-Barré syndrome associated with Epstein-Barr virus and cytomegalovirus reactivation during treatment for chronic graft-versus-host disease after allogeneic bone marrow transplantation |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.11.2023 | ||
500 | |a Date Revised 03.11.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Guillain-Barré syndrome (GBS) is a rare neurological complication of allogeneic hematopoietic stem cell transplantation (HSCT). The pathogenesis of post-HSCT GBS is unclear. Here, we report a case of GBS coincident with Epstein-Barr virus (EBV) and cytomegalovirus (CMV) reactivation that occurred after HSCT in a patient with myelodysplastic syndrome. A 61-year-old man was admitted to our hospital because of gait disturbance due to lower limb muscle weakness, which arose during treatment for chronic graft-versus-host disease (GVHD) five months after allogeneic HSCT. He was diagnosed with GBS based on his clinical course, cerebrospinal fluid analysis, and a nerve conduction study. At that time, he exhibited EBV and CMV reactivation. GBS improved after intravenous injection of immunoglobulins. Our case suggests that reactivation of EBV and CMV during treatment for chronic GVHD may induce GBS, and that rapidly progressive muscular weakness coincident with EBV or CMV reactivation can be a diagnostic sign of GBS after allogeneic HSCT | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Chronic graft-versus-host disease | |
650 | 4 | |a Cytomegalovirus | |
650 | 4 | |a Epstein-Barr virus | |
650 | 4 | |a Guillain-Barré syndrome | |
700 | 1 | |a Tane, Misato |e verfasserin |4 aut | |
700 | 1 | |a Kosako, Hideki |e verfasserin |4 aut | |
700 | 1 | |a Sakaki, Ayaka |e verfasserin |4 aut | |
700 | 1 | |a Wada, Yoshimitsu |e verfasserin |4 aut | |
700 | 1 | |a Nakayama, Yoshiaki |e verfasserin |4 aut | |
700 | 1 | |a Hiroi, Takayuki |e verfasserin |4 aut | |
700 | 1 | |a Hori, Yoshikazu |e verfasserin |4 aut | |
700 | 1 | |a Yamashita, Yusuke |e verfasserin |4 aut | |
700 | 1 | |a Mushino, Toshiki |e verfasserin |4 aut | |
700 | 1 | |a Murata, Shogo |e verfasserin |4 aut | |
700 | 1 | |a Nishikawa, Akinori |e verfasserin |4 aut | |
700 | 1 | |a Miyamoto, Katsuichi |e verfasserin |4 aut | |
700 | 1 | |a Ito, Hidefumi |e verfasserin |4 aut | |
700 | 1 | |a Sonoki, Takashi |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Rinsho ketsueki] The Japanese journal of clinical hematology |d 1972 |g 64(2023), 10 vom: 29., Seite 1280-1285 |w (DE-627)NLM000222178 |x 0485-1439 |7 nnns |
773 | 1 | 8 | |g volume:64 |g year:2023 |g number:10 |g day:29 |g pages:1280-1285 |
856 | 4 | 0 | |u http://dx.doi.org/10.11406/rinketsu.64.1280 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 64 |j 2023 |e 10 |b 29 |h 1280-1285 |